Serving as a good corporate citizen in a fast-growing CPG category is integral to Cresco Labs’ mission to normalize and professionalize cannabis. We firmly believe that how the company uses its considerable platform as an industry leader and steward for Social Impact and Diversity, Equity and Inclusion will set the proper tone towards building a responsible, respectable and robust U.S. cannabis industry. Our commitment to Social Impact and DEI starts at the top with our Board of Directors, who are wholeheartedly focused on fostering a fair workplace and engaged in the critical issues that are shaping this industry. Together with the Executive Management team, we are proud of our accomplishments, some of which are outlined below, were pioneering at the time and set an example for the industry to follow. Cresco Labs has also been extraordinarily influential in policy and regulatory efforts at the state and federal level. We favor and promote Social Equity, Diversity and Inclusion in the U.S. cannabis industry and support the decriminalization of cannabis for medicinal and adult use. We believe that all federal legislation should address injustices of historic cannabis prohibition, with a focus on disadvantaged minority communities that were disproportionately targeted for enforcement as part of the War on Drugs. Annually, we engage in hundreds of meetings on Capitol Hill with Senators and Representatives and host fundraisers and other lobbying activities to educate and ask for support for key legislation, such as SAFE Banking with capital markets. We also participate in multiple federal associations, including the National Cannabis Roundtable, of which I am the Chairman, and the U.S. Cannabis Council, which has senior leadership on Social Equity and ESG committees. In addition to federal reform, Cresco Labs has offered feedback in the statutory and rulemaking process in six states, supporting opportunities for social equity cannabis operators.